[1]
J. H. O. Hoffmann, C. Knoop, A. H. Enk, and E. N. Hadaschik, “Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveal Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists”, Acta Derm Venereol, vol. 101, no. 10, p. adv00568, Oct. 2021.